MARKET

XBIT

XBIT

Xbiotech
NASDAQ
2.500
-0.030
-1.19%
After Hours: 2.560 +0.06 +2.40% 17:45 12/19 EST
OPEN
2.530
PREV CLOSE
2.530
HIGH
2.540
LOW
2.490
VOLUME
25.24K
TURNOVER
--
52 WEEK HIGH
7.00
52 WEEK LOW
2.090
MARKET CAP
76.22M
P/E (TTM)
-2.6134
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XBIT last week (1208-1212)?
Weekly Report · 5d ago
XBiotech CEO John Simard Announces Retirement
TipRanks · 12/09 14:29
XBiotech Announces John Simard To Retire As CEO, To Continue As Chairman; Sushma Shivaswamy Appointed Interim CEO
Benzinga · 12/09 14:13
XBIOTECH INC - SUSHMA SHIVASWAMY APPOINTED INTERIM CEO OF XBIOTECH - SEC FILING
Reuters · 12/09 14:04
XBIOTECH - JOHN SIMARD TO RETIRE AS CEO; WILL CONTINUE TO SERVE AS CHAIRMAN OF BOARD OF DIRECTORS
Reuters · 12/09 14:04
XBiotech Raises Interim CEO Sushma Shivaswamy’s Salary to $750,000
Reuters · 12/09 14:01
Weekly Report: what happened at XBIT last week (1201-1205)?
Weekly Report · 12/08 09:09
Weekly Report: what happened at XBIT last week (1124-1128)?
Weekly Report · 12/01 09:08
More
About XBIT
XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases, such as inflammatory conditions like rheumatology, infectious disease, cardiovascular disease and cancer. The Company's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The Company is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. It has various candidate products, including Natrunix. It has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.

Webull offers XBiotech Inc stock information, including NASDAQ: XBIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XBIT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XBIT stock methods without spending real money on the virtual paper trading platform.